Skip to main content

Terrascend Corp(TSND-T)
TSX

Today's Change
Real-Time Last Update
Day Low0.90
Day High0.98
Open:0.95
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
GlobeNewswire
TerrAscend Appoints Eric Jackson as Chief Financial Officer
GlobeNewswire
Mike Tyson and TerrAscend Expand TYSON 2.0 Footprint into Pennsylvania and Maryland
Motley Fool
Average TFSA and RRSP Balances at Age 45: Are You on Par?
Newsfile
Upcoming Meeting Dates - March 23, 2026
GlobeNewswire
TerrAscend Reports Fourth Quarter and Full Year 2025 Financial Results
GlobeNewswire
TerrAscend to Host Fourth Quarter and Full Year 2025 Earnings Conference Call
GlobeNewswire
TerrAscend Increases Retail Footprint in New Jersey with Closing of Union Chill Dispensary Transaction
GlobeNewswire
Mike Tyson and TerrAscend Team Up To Launch Tyson 2.0 In Maryland And Pennsylvania
Baystreet
Stocks in play: TerrAscend Corp.
GlobeNewswire
TerrAscend Reports Third Quarter 2025 Financial Results
GlobeNewswire
TerrAscend Reschedules November 6th Third Quarter 2025 Earnings Conference Call to Pre-Open from Post-Market Close
AI-generated - The Globe and Mail
TerrAscend: Top 25 Undervalued Toronto Stock Exchange Stocks (TSND)
GlobeNewswire
TerrAscend to Host Third Quarter 2025 Earnings Conference Call
Newsfile
JW Asset Management Completes a Pro-Rata Distribution in Kind of Common Shares to Investors In JW Select Investments, LP and JW Opportunities Fund, LLC
GlobeNewswire
TerrAscend Announces Renewal and Replenishment of $10 Million Share Repurchase Program
GlobeNewswire
TerrAscend Reports Second Quarter 2025 Financial Results
AI-generated - The Globe and Mail
TerrAscend: Top 25 Undervalued Toronto Stock Exchange Stocks (TSND)
AI-generated - The Globe and Mail
TerrAscend: Top 10 Undervalued Drug Manufacturers Industry Stocks (TSND)
GlobeNewswire
TerrAscend to Host Second Quarter 2025 Earnings Conference Call
GlobeNewswire
TerrAscend Announces Strategic Exit from Michigan Market
AI-generated - The Globe and Mail
TerrAscend: Top 25 Undervalued Toronto Stock Exchange Stocks (TSND)
GlobeNewswire
TerrAscend Announces Results of Annual General Meeting
AI-generated - The Globe and Mail
TerrAscend: Top 10 Undervalued Drug Manufacturers Industry Stocks (TSND)
GlobeNewswire
TerrAscend Announces Chief Financial Officer Transition Plan
AI-generated - The Globe and Mail
TerrAscend: Top 10 Undervalued Drug Manufacturers Industry Stocks (TSND)
GlobeNewswire
TerrAscend Reports First Quarter 2025 Financial Results
AI-generated - The Globe and Mail
TerrAscend: Top 10 Undervalued Drug Manufacturers Industry Stocks (TSND)
GlobeNewswire
TerrAscend to Host First Quarter 2025 Earnings Conference Call
AI-generated - The Globe and Mail
TerrAscend: Top 10 Undervalued Drug Manufacturers Industry Stocks (TSND)
GlobeNewswire
TerrAscend Reports Fourth Quarter and Full Year 2024 Financial Results
AI-generated - The Globe and Mail
TerrAscend: Top 10 Undervalued Healthcare Sector Stocks on TSX (TSND)
AI-generated - The Globe and Mail
TerrAscend: Top 10 Undervalued Drug Manufacturers Industry Stocks (TSND)

Profile

TerrAscend Corp is a company focused on creating and delivering cannabis products and services that meet the evolving needs of its patients. It also provides education and support programs to physicians and patients through healthcare professionals. In addition, the firm operates in California, Maryland, New Jersey, and Pennsylvania, with retail operations in Ohio and Canada. It operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. The firm has one operating segment, being the cultivation, production, and sale of cannabis products, with subsidiaries located in Canada and the United States. The company generates key revenue from the United States.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.